The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Stratified monotherapy approach according to MGMT methylation status in elderly patients with glioblastoma.
 
Mitsuaki Shirahata
No Relationships to Disclose
 
Junichi Adachi
Speakers' Bureau - Eisai; UCB
Research Funding - Chugai Pharma; Eisai; MSD
 
Keiichi Kobayashi
Honoraria - Daiichi Sankyo; Eisai; UCB
 
Fumiyuki Yamasaki
No Relationships to Disclose
 
Kaoru Tamura
No Relationships to Disclose
 
Tomonari Suzuki
Research Funding - Chugai Pharma; Eisai; MSD
 
Kazuhiko Mishima
Speakers' Bureau - Chugai Pharma; Ono Pharmaceutical
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Medical U and A, Inc (Inst); MSD (Inst); Nihon Medi-Physics (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Teijin Pharma (Inst)
 
Motoo Nagane
Honoraria - Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Infront; MSD; Nippon Kayaku; Novocure; Ono Pharmaceutical; Springer
Consulting or Advisory Role - Abbvie; Chugai Pharma; Dainippon Sumitomo Pharma; Novocure
Research Funding - Abbvie; Astellas Pharma (Inst); Chugai Pharma; CSL Behring (Inst); Daiichi Sankyo; Eisai; HOYA Techonosurgical (Inst); MSD; Nihonkayaku (Inst); Ono Pharmaceutical; Otsuka (Inst); Pfizer (Inst); Saney Seiko (Inst); Sanofi (Inst); Sanofi (Inst); Shionogi (Inst); Takeda (Inst); Toray Industries; Tsumura & Co. (Inst); Tsumura & Co. (Inst)
Patents, Royalties, Other Intellectual Property - Toray Industries
Travel, Accommodations, Expenses - Abbvie; Chugai Pharma; Daiichi Sankyo; Eisai; MSD K.K; Ono Pharmaceutical
 
Koichi Ichimura
Honoraria - Convex; Eisai; Nobelpharma; Sumitomo Group
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Chugai Pharma; Daiichi Sankyo; Eisai; EPS Associates Co., Ltd.
Travel, Accommodations, Expenses - Convex; Eisai; Nobelpharma; Sumitomo Group
 
Ryo Nishikawa
Honoraria - Abbvie; Chugai Pharma; Eisai; MSD
Consulting or Advisory Role - Daiichi Sankyo; Novocure; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); MSD (Inst)
Expert Testimony - Daiichi Sankyo; Novocure; Ono Pharmaceutical